1
16 Chem. Res. Toxicol., Vol. 23, No. 1, 2010
Wynalda and Murphy
of ozone typically encountered in the environment are present.
Plasmalogens were found to encompass ∼38% of total PE lipids
within surfactant, and the vinyl ether bond was shown to react
with ozone. Analysis of PE phospholipid products generated in
this experiment revealed a significant increase in lysophospho-
lipids, which are known to induce an array of biological
activities (46-48). The oxidation of plasmalogens may therefore
be a potential source of secondary bioactive lipids, produced
by low concentrations of ozone found in the environment.
(16) Stadelmann-Ingrand, S., Pontcharraud, R., and Fauconneau, B. (2004)
Evidence for the reactivity of fatty aldehydes released from oxidized
plasmalogens with phosphatidylethanolamine to form Schiff base
adducts in rat brain homogenates. Chem. Phys. Lipids 131, 93–105.
(17) Murphy, R. C. (2001) Free-radical-induced oxidation of arachidonoyl
plasmalogen phospholipids: Antioxidant mechanism and precursor
pathway for bioactive eicosanoids. Chem. Res. Toxicol. 14, 463–472.
(
18) Diagne, A., Fauvel, J., Record, M., Chap, H., and Douste-Blazy, L.
(
1984) Studies on ether phospholipids. II. Comparative composition
of various tissues from human, rat and guinea pig. Biochim. Biophys.
Acta 793, 221–231.
19) Zoeller, R. A., Lake, A. C., Nagan, N., Gaposchkin, D. P., Legner,
M. A., and Lieberthal, W. (1999) Plasmalogens as endogenous
antioxidants: somatic cell mutants reveal the importance of the vinyl
ether. Biochem. J. 338 (Part 3), 769–776.
(
Acknowledgment. This work was supported by a grant from
the National Institutes of Health (HL034303). Special thanks
to Dr. Lynn Heasely, Dr. Christine Wu, and PharmOptima for
their kind donation of mice to the surfactant studies and Dr.
Lori Nield, Brad Barrett, and Jason Fritz for their assistance
with BAL techniques and advice.
(
(
20) Engelmann, B. (2004) Plasmalogens: targets for oxidants and major
lipophilic antioxidants. Biochem. Soc. Trans. 32, 147–150.
21) Rustow, B., Kolleck, I., Guthmann, F., Haupt, R., Kunze, D., and
Stevens, P. (1994) Sythesis and secretion of plasmalogens by type II
pneumocytes. Biochem. J. 302, 665–668.
(
(
(
22) Schmidt, R., Luboeinski, T., Markart, P., Ruppert, C., Daum, C.,
Grimminger, F., Seeger, W., and Gunther, A. (2004) Alveolar
antioxidant status in patients with acute respiratory distress syndrome.
Eur. Respir. J. 24, 994–999.
23) Zemski Berry, K. A., Turner, W. W., VanNieuwenhze, M. S., and
Murphy, R. C. (2009) Stable isotope labeled 4-(dimethylamino)benzoic
acid derivatives of glycerophosphoethanolamine lipids. Anal. Chem.
Supporting Information Available: Figure of ozone con-
centrations of 1-hydroxy-2-nonanal-PE and 1-formyl-2-nonanal-
PE, figure of chromatographic separation of increasing lyso-
phospholipids found after ozonolysis of lung surfactant, and
work flow diagram to schematically indicate steps used to
differentially label experimental samples. This material is
available free of charge via the Internet at http://pubs.acs.org.
8
1, 6633–6640.
24) Notter, R. (2000) Lung biology in health and disease. In Lung
Surfactants: Basic Science and Clinical Applications (Lenfant, C., Ed.)
Marcel Dekker, New York.
(
25) Kim, H. Y., and Salem, N., Jr. (1990) Separation of lipid classes by
solid phase extraction. J. Lipid Res. 31, 2285–2289.
References
(
26) Zemski Berry, K. A., and Murphy, R. C. (2004) Electrospray ionization
tandem mass spectrometry of glycerophosphoethanolamine plasmalo-
gen phospholipids. J. Am. Soc. Mass Spectrom. 15, 1499–1508.
(
1) Ciencewicki, J., Trivedi, S., and Kleeberger, S. R. (2008) Oxidants
and the pathogenesis of lung diseases. J. Allergy Clin. Immunol. 122,
4
56–468.
(27) Snyder, F., Blank, M. L., and Wykle, R. L. (1971) The enzymic
synthesis of ethanolamine plasmalogens. J. Biol. Chem. 246, 3639–
3645.
(
2) Finlayson-Pitts, B. J., and Pitts, J. N. (2000) Chemistry of the Upper
and Lower Atmosphere, Academic Press, San Diego, CA.
(
3) Tong, D. Q., Yu, S., and Kan, H. (2009) Ozone exposure and mortality.
(28) Bligh, E. G., and Dyer, W. J. (1959) A rapid method of total lipid
extraction and purification. Can. J. Biochem. Physiol. 37, 911–917.
(29) Luo, X. P., Yazdanpanah, M., Bhooi, N., and Lehotay, D. C. (1995)
Determination of aldehydes and other lipid peroxidation products in
biological samples by gas chromatography-mass spectrometry. Anal.
Biochem. 228, 294–298.
(30) Hadley, J. S., Fradin, A., and Murphy, R. C. (1988) Electron capture
negative ion chemical ionization analysis of arachidonic acid. Biomed.
EnViron. Mass Spectrom. 15, 175–178.
(31) Clay, K. (1990) Arachidonate related lipid mediators. In Methods in
Enzymology (Murphy, R. C., Fitzpatrick, F. A., Ed.) Academic Press,
San Diego.
(32) Creer, M. H., and Gross, R. W. (1985) Separation of isomeric
lysophospholipids by reverse phase HPLC. Lipids 20, 922–928.
(33) Hurly, B. P., and McCormick, B. A. (2008) Multiple roles of
N. Engl. J. Med. 360, 2788–2789.
(
4) Michalec, L., Choudhury, B. K., Postlethwait, E., Wild, J. S., Alam,
R., Lett-Brown, M., and Sur, S. (2002) CCL7 and CXCL10 orchestrate
oxidative stress-induced neutrophilic lung inflammation. J. Immunol.
1
68, 846–852.
5) Bernard, A., Carbonnelle, S., Nickmilder, M., and de Burbure, C.
2005) Non-invasive biomarkers of pulmonary damage and inflam-
(
(
mation: Application to children exposed to ozone and trichloramine.
Toxicol. Appl. Pharmacol. 206, 185–190.
(
6) Brown, J. S., Bateson, T. F., and McDonnell, W. F. (2008) Effects of
exposure to 0.06 ppm ozone on FEV1 in humans: A secondary analysis
of existing data. EnViron. Health Perspect. 116, 1023–1026.
7) Schelegle, E. S., Morales, C. A., Walby, W. F., Marion, S., and Allen,
R. P. (2009) 6.6-h inhalation of ozone concentrations from 60 to 87
parts per billion in healthy humans. Am. J. Respir. Crit. Care Med.
(
2
phospholipase A during lung infection and inflammation. Infect.
Immun. 76 (6), 2259–2272.
1
80, 265–272.
(
8) Hoppe, P., Peters, A., Rabe, G., Praml, G., Lindner, J., Jakobi, G.,
Fruhmann, G., and Nowak, D. (2003) Environmental ozone effects in
different population subgroups. Int. J. Hyg. EnViron. Health 206, 505–
(34) De Luca, D., Silvia, B., Vento, G., Piastra, M, Pietrini, D., Romitelli,
F., Capoluongo, E., Romagnoli, C., Conti, G., and Zecca, E. (2008)
Secretory phospholipases A2 and neonatal respiratory distress: Pilot
study on broncho-alveolar lavage. IntensiVe Care Med. 34, 1858–1864.
(35) Arbibe, L., Koumanov, K., Vial, D., Rougeot, C., Faure, G., Havet,
N., Longacre, S., Vargaftig, B. B., Bereziat, G., Voelker, D. R., Wolf,
C., and Touqui, L. (1998) Generation of lysophospholipids from
surfactant in acute lung injury is mediated by type-II phospholipase
A2 and inhibited by a direct surfactant protein A-phospholipase protein
interaction. J. Clin. InVest. 102, 1152–1160.
(36) Grosjean, E, and Grosjean, D. (1999) The reaction of unsaturated
aliphatic oxygenates with ozone. J. Atmos. Chem. 32 (1), 205–232.
(37) Grosjean, E, and Grosjean, D. (1998) Rate constants for the gas phase
reaction of ozone with unsaturated oxygenates. Int. J. Chem. Kinet.
30 (1), 21–29.
5
16.
(
9) Devlin, R. B., McDonnell, W. F., Mann, R., Becker, S., House, D. E.,
Schreinemachers, D., and Koren, H. S. (1991) Exposure of humans
to ambient levels of ozone for 6.6 h causes cellular and biochemical
changes in the lung. Am. J. Respir. Cell Mol. Biol. 4, 72–81.
(
(
(
10) Thurston, G. D., Lippmann, M., Scott, M. B., and Fine, J. M. (1997)
Summertime haze air pollution and children with asthma. Am. J.
Respir. Crit. Care Med. 155, 654–660.
11) Pryor, W. A. (1992) How far does ozone penetrate into the pulmonary
air/tissue boundary before it reacts? Free Radical Biol. Med. 12, 83–
8
8.
12) Dahl, M., Bauer, A. K., Arredouani, M., Soininen, R., Tryggvason,
K., Kleeberger, S. R., and Kobzik, L. (2007) Protection against inhaled
oxidants through scavenging of oxidized lipids by macrophage
receptors MARCO and SR-AI/II. J. Clin. InVest. 117, 757–764.
13) Postlethwait, E. M. (2007) Scavenger receptors clear the air. J. Clin.
InVest. 117, 601–604.
14) Pulfer, M. K., and Murphy, R. C. (2004) Formation of biologically
active oxysterols during ozonolysis of cholesterol present in lung
surfactant. J. Biol. Chem. 279, 26331–26338.
15) Uhlson, C., Harrison, K., Allen, C. B., Ahmad, S., White, C. W., and
Murphy, R. C. (2002) Oxidized phospholipids derived from ozone-
treated lung surfactant extract reduce macrophage and epithelial cell
viability. Chem. Res. Toxicol. 15, 896–906.
(38) Pryor, W. A., Giamalva, D., and Church, D. F. (1985) Kinetics of
ozonation. 3. Substituent effects on the rates of reaction of alkenes.
J. Am. Chem. Soc. 107, 2793–2797.
(
(
(39) Criegee, R. (1975) Mechanism of ozonolysis. Angew Chem. Int. Ed.
14 (11), 745–752.
(40) Bernhard, W., Wand, J., Tschernig, T., Tummler, B., Hedrich, H. J.,
and von der Hardt, H. (1997) Lung surfactant in a cystic fibrosis animal
model: Increased alveolar phospholipid pool size without altered
2
HGU/m2HGU
(
composition and surface tension function in cftrm
mice.
Thorax 52, 723–730.
(41) Nakos, G., Kitsiouli, E., Hatzidaki, E., Koulouras, V., Touqui, L., and
Lekka, M. (2005) Phospholipases A and platelet-activating-factor
2